Milestone Pharmaceuticals Inc. (MIST)

NMS – Real Time Price. Currency in USD

1.13

-0.14 (-11.42%)

At close: Aug 12, 2026, 4:00 PM EDT

1.13

+0.01 (0.44%)

After-hours: Aug 12, 2026, 6:30 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-114K

-646K

-598K

-480K

Gross Profit

-646K

402K

Operating expenses (excl. COGS)

-64M

-42M

-62M

-65M

Operating Income

-62M

-42M

-61M

-60M

Non-operating income, total

-918K

583K

Pretax income

-63M

-42M

-60M

-59M

Equity in earnings

Taxes

345K

259K

312K

456K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-63M

-42M

-60M

-58M

Discontinued operations

Net income

-63M

-42M

-60M

-58M

Dilution adjustment

Preferred dividends

Milestone Pharmaceuticals Inc. (MIST)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Milestone Pharmaceuticals Inc. (MIST)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Milestone Pharmaceuticals Inc. (MIST)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Milestone Pharmaceuticals Inc. (MIST)

Income Statement (Annual)

Income Statement (Annual)